Search Results 791-800 of 18306 for SARS

  1. Publications - Loralie J. Langman, Ph.D. - Mayo Clinic

    Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions.

  2. A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment - Mayo Clinic

    - Active HBV, HCV, SARS-CoV2, HIV, or any active, uncontrolled bacterial, fungal, or viral infection - Any other active malignancy within 3 years prior to ...

  3. A Study To Evaluate The Effectiveness And Safety Of CC-93538 To Treat Adults And Adolescents With Eosinophilic Esophagitis - Mayo Clinic

    Subject had a previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection within 4 weeks prior to screening. Symptoms must have ...

  4. What is aspirin-exacerbated respiratory disease (AERD)? - Mayo Clinic

    AERD, also called Samter's triad, has three features: asthma, recurring nasal polyps, and sensitivity to aspirin and drugs such as ibuprofen and naproxen.

  5. A Study to Compare CMP-001 Combined with Nivolumab to Nivolumab Alone in Advanced Melanoma Subjects - Mayo Clinic

    Known or suspected active infection with severe acute respiratory syndrome coronavirus 2 virus (SARS-CoV-2). Active infection requiring systemic therapy. 16 ...

  6. https://www.mayoclinic.org/chinese_patient_consumer_recipe.xml

  7. Science Saturday: Macrophage communication is key during viral infection - Mayo Clinic News Network

    We think that our results have suggested not only possible treatment options for severe viral infection such as influenza and SARS-CoV2, but also a new ...

  8. https://www.mayoclinic.org/arabic_condition_consolidated_concepts.xml

  9. Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia - Mayo Clinic

    Evidence of active infection, including suspected or laboratory confirmed SARS-COVID-19 virus less than 14 days prior to first dose of study intervention.

  10. A Trial of the Effectiveness, Safety, and Tolerability of a Single Oral Administration of CP101 for the Prevention of Recurrent Clostridioides difficile Infection (PRISM4) - Mayo Clinic

    Screening nasopharyngeal PCR test is positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Any acute, chronic, or unstable medical ...